Svenska
Boston
An independent LDT provider
Home
About us
Home
About us
Learn more
Vision and mission
Leadership
About us
Leadership
Learn more
Board of directors
Management team
Medical Advisory Board
Collaborations
About us
Collaborations
Learn more
Patient Advocacy Support
Immunovia, Inc.
Company history
Sustainability
About us
Sustainability
Learn more
Sustainability report
Code of conduct
Work environment
Diversity
Calendar
Careers
Pancreatic Cancer
Home
Pancreatic Cancer
Learn more
Pancreatic cancer high risk groups
Clinical performance
Clinical prospective study program
Current technologies for detection and diagnosis
Investors
Media
Home
Media
Learn more
Press releases
Presentations
Webinars
Tutorials
Videos
Audio
Publications
Media resources
Partnering
Contact Us
Subscribe
English
Svenska
NOTE:
Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here:
https://rb.gy/09bxx
Press releases
Type
All types
Regulatory
Non regulatory
Year
All years
2023
2022
2021
2020
2019
2018
2017
2016
2015
March 16, 2023
| REGULATORY
Bulletin from the extraordinary general meeting in Immunovia AB
Read press release
March 1, 2023
| REGULATORY
Immunovia appoints Karl Stone as new chief operating officer to develop R&D and operations
Read press release
February 23, 2023
| REGULATORY
Immunovia Publishes Full Year Report for 2022
Read press release
February 20, 2023
Invitation to Immunovia’s Q4 presentation
Read press release
February 20, 2023
| REGULATORY
CONVENING NOTICE – EXTRAORDINARY GENERAL MEETING IN IMMUNOVIA AB (publ)
Read press release
February 20, 2023
| REGULATORY
Immunovia resolves on a rights issue of approximately SEK 202.2 million and postpones the publication of the quarterly report for the first quarter and the annual general meeting
Read press release
February 8, 2023
Consultation process with Swedish unions completed
Read press release
January 19, 2023
Immunovia announces updated financial calendar for financial year 2023
Read press release
January 19, 2023
Immunovia realigning Swedish operations with strategic priorities and its focus on the US commercialization of the IMMray™ PanCan-d test
Read press release
January 17, 2023
Immunovia Appoints Lara E. Sucheston-Campbell as Head of Clinical and Medical Affairs to Accelerate Commercial strategy of IMMray™ PanCan-d test in the US market
Read press release
December 5, 2022
Immunovia strengthens US organization to continue commercialization of its novel IMMray™ PanCan-d test
Read press release
November 30, 2022
Centers for Medicare & Medicaid Services finalizes its payment determination and sets a rate of $897 for Immunovia’s IMMray PanCan-d test
Read press release
<
1
2
3
4
5
…
27
>
Home
Press releases
Page 3